BioCentury
ARTICLE | Company News

Apricus Biosciences, Bracco S.p.A. sales and marketing update

January 3, 2011 8:00 AM UTC

Apricus (formerly NexMed Inc.) granted Bracco exclusive rights to commercialize and market Vitaros alprostadil in Italy as first-line treatment of erectile dysfunction (ED). Apricus is eligible to r...